The endothelium in the pathogenesis of systemic sclerosis: is it primary or secondary?
Furst, D.E.
Journal des Maladies Vasculaires 24(2): 95-98
1999
ISSN/ISBN: 0398-0499 PMID: 10399641 Document Number: 507926
Document emailed within 1 workday
Related Documents
Della Bella, S.; Molteni, M.; Mocellin, C.; Fumagalli, S.; Bonara, P.; Scorza, R. 2001: Lymphocyte-endothelium interaction in systemic sclerosis and Raynaud's phenomenon Clinical and Experimental Rheumatology 19(6): 647-654Penning, C.A.; Cunningham, J.; French, M.A.; Harrison, G.; Rowell, N.R.; Hughes, P. 1984: Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis Clinical and Experimental Immunology 57(3): 548-556
LeRoy, E.C.; Black, C.; Fleischmajer, R.; Jablonska, S.; Krieg, T.; Medsger, T.A.; Rowell, N.; Wollheim, F. 1988: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis Journal of Rheumatology 15(2): 202-205
Radić, M.; Kaliterna, D.M.ć; Fabijanić, D.; Radić, J. 2010: Systemic sclerosis--pathogenesis, clinical manifestations and treatment Lijecnicki Vjesnik 132(5-6): 162-168
Radić, M.; Martinović Kaliterna, D.; Radić, J. 2010: Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis Netherlands Journal of Medicine 68(11): 348-353
Uras, C.; Tabolli, S.; Giannantoni, P.; Rocco, G.; Abeni, D. 2014: The Italian version of the Systemic Sclerosis Questionnaire: a comparison of quality of life in patients with systemic sclerosis and with other connective tissue disorders Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(5): 539-548
Shalev, L.; Langevitz, P.; Zandman-Goddard, G. 2008: Long-term therapy with endothelin-1 antagonist for pulmonary hypertension secondary to systemic sclerosis Harefuah 147(4): 287-289; 376
Mastrapasqua, G.; Zappalà, G.; Beltramello, G.; Madia, D.; Virone, C.; Spolaore, P.; Visonà, A.; Cavallin, F.; D'Este, R. 1983: Association of primary biliary cirrhosis and systemic sclerosis. A new case Recenti Progressi in Medicina 74(2): 151-157
Allanore, Y.; Meune, C. 2010: Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin Clinical and Experimental Rheumatology 28(5 Suppl 62: S48-S53
Kawald, A.; Burmester, G.R.; Huscher, D.ör.; Sunderkötter, C.; Riemekasten, G. 2008: Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study Journal of Rheumatology 35(9): 1830-1837
Krajka-Lauer, J.ła.; Mazurkiewicz-Bełdzińska, M.; Lauer, W.; Kokot, W.; Lass, P.; Czuszyńska, Z.; Luksza, L.; Iwaszkiewicz-Bilikiewicz, B. 2004: Frequency of appearance systemic complications of autoimmunological diseases: primary and secondary Sjögren syndrome Klinika Oczna 106(3 Suppl): 466-468
Maricq, H.R.; Diat, F.; Weinrich, M.C.; Maricq, J.G. 1994: Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon Journal of Rheumatology 21(8): 1472-1476
Stepień, M.; Cendrowski, W. 1974: Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis Neurologia i Neurochirurgia Polska 8(4): 607-609
Gawrysiak, W.; Skrypnik, K.; Suliburska, J.; Skrypnik, D.; Bogdański, Pł. 2017: Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis Przeglad Lekarski 74(4): 179-182
Obata, T.; Takahashi, H.; Nosho, K.; Ikeda, Y.; Tokuno, T.; Kawahito, Y.; Honda, S.; Makiguchi, Y.; Imai, K.; Ikeda, T. 1998: A case of systemic lupus erythematosus overlapping with progressive systemic sclerosis accompanied by deposition of AA amyloid in the stomach Ryumachi 38(6): 810-817
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Shevchenko, I.L.; Stoĭko, I.M.; Gudymovich, V.G.; Nikitina, A.M. 2013: Endothelium-dependent factors of pathogenesis of a relapse of varicose disease: a diagnostic concept and treatment policy Angiologiia i Sosudistaia Khirurgiia 19(3): 20-24
Titov, V.N. 2008: Concomitant impairments of essential fatty acids and endothelium-dependent vasodilation in the pathogenesis of arterial hypertension and atherosclerosis Klinicheskaia Laboratornaia Diagnostika 10: 3-14
Sluiter, W.; Pietersma, A.; Lamers, J.M.; Koster, J.F. 1993: Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression Journal of Cardiovascular Pharmacology 22(Suppl): S37-S44